Cargando…
Preclinical approaches in chronic myeloid leukemia: from cells to systems
Advances in the design of targeted therapies for the treatment of chronic myeloid leukemia (CML) have transformed the prognosis for patients diagnosed with this disease. However, leukemic stem cell persistence, drug intolerance, drug resistance, and advanced-phase disease represent unmet clinical ne...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Science Inc
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333535/ https://www.ncbi.nlm.nih.gov/pubmed/28017647 http://dx.doi.org/10.1016/j.exphem.2016.11.005 |